Evidence map›Paper›PMID 40457346›Full record

ArticleBMC public health2025

The prevalence of homelessness and its associated factors among people who inject drugs in Iran: results from nationwide bio-behavioral surveillance surveys in 2020 and 2023.

Seyed Aria Nejadghaderi, Azin Kadkhodamanesh, Soheil Mehmandoost, Meraj Sharifi, Fatemeh Tavakoli, Maliheh Sadat Bazrafshani, Mehrdad Khezri, Hossein Mirzaie, Naser Nasiri, Sakineh Bajelan and 3 more

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Seyed Aria Nejadghaderi *HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Azin Kadkhodamanesh *HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Soheil MehmandoostHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Meraj SharifiHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Fatemeh TavakoliHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. fatemehtavakoli98@yahoo.com.
Maliheh Sadat BazrafshaniHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Mehrdad KhezriHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Hossein MirzaieHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Naser NasiriHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Sakineh BajelanAlborz University of Medical Sciences, Alborz, Iran.
Marieh SattariLorestan University of Medical Sciences, Khorramabad, Iran.
Abedin IranpourHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Hamid SharifiHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. sharifihami@gmail.com.

Funding

National Institute for Medical Research Development 973382World Health Organization, Iran 2022/1296402-0
6 · The paper itself

Abstract

backgroundHomelessness among people who inject drugs (PWID) represents a significant and complex public health challenge. However, few studies have investigated the factors contributing to its prevalence, particularly in the Middle East and North Africa region. We aimed to determine homelessness’s prevalence and associated factors among PWID in Iran from July 2019 to March 2020 and between May and August 2023.

methodsThis study analyzed data from two national surveys (2020 and 2023) in Iran, focusing on PWID aged over 18. Participants were interviewed about their demographics, substance use, health behaviors, and experiences with homelessness. Multinomial logistic regression determined homelessness-related factors in the past 12 months or over 12 months for merged data of both years.

resultsIn 2020, 2632 participants, and in 2023, 2371 PWID were included in the analysis. The prevalence of homelessness in the past 12 months was 43.2% (95% Confidence Intervals [CI]: 41.3, 45.1) in 2020 and 47.6% (95% CI: 45.6–49.6) in 2023. Multivariable multinomial logistic regression showed that being aged ≥ 30 years (adjusted Odds Ratio [aOR]: 2.13, 95% CI: 1.66–2.72), having high school education or higher (aOR: 0.74, 95% CI: 0.65–0.85), age of first drug use < 18 years (aOR: 1.61, 95% CI: 1.41–1.85), and the lifetime history of HIV testing (aOR: 1.36, 95% CI: 1.17–1.58) were significantly associated with homelessness in the past 12 months. Being aged ≥ 30 years (aOR: 1.62, 95% CI: 1.14–2.31), having high school education or higher (aOR: 0.71, 95% CI: 0.59–0.87), age of first drug use < 18 years (aOR: 1.47, 95% CI: 1.21–1.78), and lifetime history of HIV testing (aOR: 1.76, 95% CI: 1.40–2.22) also had significant associations with homelessness in more than 12 months.

conclusionsOur findings suggest that sociodemographic characteristics, substance use patterns, and health behaviors significantly contribute to the likelihood of homelessness among PWID. Housing-supportive programs integrated with harm reduction interventions are recommended to mitigate homelessness and its related challenges.

Indexed as

Ill-Housed PersonsSubstance Abuse, IntravenousAdolescentAdultFemaleHumansIranMaleMiddle AgedPrevalenceRisk FactorsSurveys and QuestionnairesYoung AdultDrug usersIll-housed personsIntravenousIranPrevalenceSubstance abuseSubstance-related disorders

Identifiers

PMID40457346
PMCPMC12128355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.